Brian P. Mckeon - Nov 10, 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role: Executive VP & CFO
Signature: /s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
Stock symbol: IDXX
Transactions as of: Nov 10, 2021
Transactions value $: -$11,142,279
Form type: 4
Date filed: 11/12/2021, 04:29 PM
Previous filing: Nov 10, 2021
Next filing: Nov 15, 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IDXX	Common Stock	Options Exercise	$1.36M	+20K	+76%	$67.85^*	46.3K	Nov 10, 2021	Direct
transaction	IDXX	Common Stock	Sale	-$784K	-1.26K	-2.72%	$621.40	45.1K	Nov 10, 2021	Direct	F1
transaction	IDXX	Common Stock	Sale	-$3.57M	-5.74K	-12.75%	$622.36	39.3K	Nov 10, 2021	Direct	F2
transaction	IDXX	Common Stock	Sale	-$931K	-1.49K	-3.8%	$623.34	37.8K	Nov 10, 2021	Direct	F3
transaction	IDXX	Common Stock	Sale	-$1.34M	-2.14K	-5.66%	$624.53	35.7K	Nov 10, 2021	Direct	F4
transaction	IDXX	Common Stock	Sale	-$1.45M	-2.33K	-6.52%	$625.46	33.4K	Nov 10, 2021	Direct	F5
transaction	IDXX	Common Stock	Sale	-$1.14M	-1.81K	-5.44%	$626.74	31.5K	Nov 10, 2021	Direct	F6
transaction	IDXX	Common Stock	Sale	-$1.87M	-2.97K	-9.43%	$627.97	28.6K	Nov 10, 2021	Direct	F7
transaction	IDXX	Common Stock	Sale	-$865K	-1.38K	-4.81%	$628.78	27.2K	Nov 10, 2021	Direct	F8
transaction	IDXX	Common Stock	Sale	-$549K	-872	-3.21%	$629.80	26.3K	Nov 10, 2021	Direct	F9
holding	IDXX	Common Stock						18.1K	Nov 10, 2021	by Estony McKeon Family, LLC

Showing 1 to 11 of 11 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IDXX	Non-Qualified Stock Option (right-to-buy)	Options Exercise		-20K	-68.43%		9.23K	Nov 10, 2021	Common Stock	20K	$67.85	Direct	F10, F11

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $620.78 to $621.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2	This transaction was executed in multiple trades at prices ranging from $621.79 to $622.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $622.97 to $623.965. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	This transaction was executed in multiple trades at prices ranging from $624.04 to $625.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5	This transaction was executed in multiple trades at prices ranging from $625.06 to $626.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6	This transaction was executed in multiple trades at prices ranging from $626.10 to $627.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7	This transaction was executed in multiple trades at prices ranging from $627.32 to $628.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8	This transaction was executed in multiple trades at prices ranging from $628.34.10 to $629.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9	This transaction was executed in multiple trades at prices ranging from $629.46 to $630.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F10	Grant of option to buy 45,535 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2017.
F11	Not applicable.